🟢 Bayer is trading 4.3% up today as an outlook increase lifted shares

Bayer is trading at €56.58, up 4.31%, after Q3 results and a higher full-year outlook lifted shares.

• Sales and adjusted EBITDA rose, with Pharmaceuticals driving growth.
• Reuters reported that pharma performance beat expectations. Bayer raised its full-year outlook for pharma margin, group EBITDA and free cash flow.
• Broad U.S. markets were falling, but that market context does not explain Bayer’s gain.